BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31983191)

  • 41. GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas.
    Oztürk O; Isbir T; Yaylim I; Kocatürk CI; Gürses A
    In Vivo; 2003; 17(6):625-32. PubMed ID: 14758730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
    Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
    Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
    Roszak A; Lianeri M; Sowińska A; Jagodziński PP
    Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
    Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
    Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types.
    Alexandrie AK; Sundberg MI; Seidegård J; Tornling G; Rannug A
    Carcinogenesis; 1994 Sep; 15(9):1785-90. PubMed ID: 7923570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians.
    Sakai K; Loza E; Roig GV; Nozaki R; Asai T; Ikoma T; Tsuchiya Y; Kiyohara C; Yamamoto M; Nakamura K
    Asian Pac J Cancer Prev; 2016; 17(2):781-4. PubMed ID: 26925680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 48. [Correlation between smoking and the polymorphisms of cytochrome P450 1A1-Msp I and glutathione S-transferase T1 genes and oral cancer].
    Guo L; Zhang C; Shi S; Guo X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2012 Apr; 30(2):187-91. PubMed ID: 22594240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.
    Gutman G; Morad T; Peleg B; Peretz C; Bar-Am A; Safra T; Grisaru D
    Int J Gynecol Cancer; 2009 Nov; 19(8):1300-2. PubMed ID: 20009880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Association of nasopharyngeal carcinoma risk with cytochrome P450 CYP1A1 gene polymorphisms].
    Xu YF; Pan QH; Cui C; Chen LZ; Feng QS; Zeng YX; Jia WH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):586-90. PubMed ID: 19954069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
    Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of CYP1A1 haplotypes in modulating susceptibility to coronary artery disease.
    Lakshmi SV; Naushad SM; Saumya K; Rao DS; Kutala VK
    Indian J Biochem Biophys; 2012 Oct; 49(5):349-55. PubMed ID: 23259321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer.
    Sabitha K; Reddy MV; Jamil K
    Cancer Epidemiol; 2010 Oct; 34(5):587-92. PubMed ID: 20887941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
    Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
    Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
    Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
    Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
    Inoue K; Asao T; Shimada T
    Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1 as an Important Associated Locus.
    Sengupta D; Guha U; Mitra S; Ghosh S; Bhattacharjee S; Sengupta M
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2071-2081. PubMed ID: 30139066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer.
    Mota P; Moura DS; Vale MG; Coimbra H; Carvalho L; Regateiro F
    Rev Port Pneumol; 2010; 16(1):89-98. PubMed ID: 20054510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.
    Murata M; Watanabe M; Yamanaka M; Kubota Y; Ito H; Nagao M; Katoh T; Kamataki T; Kawamura J; Yatani R; Shiraishi T
    Cancer Lett; 2001 Apr; 165(2):171-7. PubMed ID: 11275366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.